HIV, lenacapavir and Data

Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center, collaborates with researchers from the Kenya Medical Research Institute ...
| Real-world evidence lets us see how HIV medicines work in real life, helping HCPs provide better care and improving ...
Health Cabinet Secretary Deborah Barasa has reaffirmed Kenya's dedication to providing uninterrupted care for individuals living with HIV, despite recent challenges stemming from a freeze in foreign ...
Lynae Darbes, PhD, presented research on the effectiveness of a home-based intervention for HIV prevention among couples ...
Disparities in HIV diagnosis rates were observed between Black and White individuals in the US from 2017 to 2021.
A new study published in The Lancet HIV reveals gaps in knowledge surrounding the prevention of HPV-related cancers in people living with HIV and outlines future research priorities.
HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.